e 1

Generally speaking , μ is a nonlinear function of deformation state and E 1 .

一般说来，它将是变形状态及E1的非线性函数。

Objective To investigate the effects of prostaglandin E 1 treatment to cerebral infarction .

目的探讨前列腺素E1治疗脑梗塞的疗效。

Clinical Application of Prostaglandin E 1 in Cardiovascular Diseases

前列腺素E1在心血管疾病中的临床应用

Treatment of pulmonary heart disease with prostaglandin E 1 : A prospective study of 61 cases

前列腺素E1治疗61例肺心病效果观察

A problem for existence of limit cycle in a system E 1 3 with a hyperbolic solution

具有双曲线解xy－1＝0的系统E13的极限环的存在性问题

Therapeutic effectiveness of prostaglandin E 1 on acute obstructive cholangitis : Experimental study

前列腺素E1对急性梗阻性胆管炎治疗作用的实验研究

Clinical Study of Treatment of Impotence with per Urethra Administration of Prostaglandin E 1

经尿道给予前列腺素E1治疗阳萎的临床研究

Effects of prostaglandin E 1 on cardiovascular stress response to endotracheal intubation

前列腺素E1预防全麻气管内插管心血管副反应的观察

Clinical Study on Thrombolysis of Deep Venous Thrombosis Using Urokinase Plus Prostaglandin E 1

尿激酶和前列腺素E1联合溶解深静脉血栓的临床研究

Effects of small dose prostaglandin E 1 on severe congestive heart failure and serum endothelin level

小剂量前列腺素E1对严重充血性心力衰竭及内皮素的影响

Clinical analysis on Treating 46 cases of cirrhotic portal hypertention with prostaglandin E 1

前列腺素E1治疗肝硬化门静脉高压症46例

Hypotension induced by prostaglandin E 1 during cerebral aneurysm operations

前列腺素E1控制性降压下行颅内动脉瘤夹闭术28例

Protective effect of liposome carried prostaglandin E 1 on limb ischemia reperfusion injury in rats

脂质体携载前列腺素E1对大鼠肢体缺血&再灌注损伤的保护作用

The renal function protection of prostaglandin E 1 from hemolysis caused by cardiopulmonary bypass

前列腺素E1对体外循环溶血引起的肾功能损害的保护作用

Conclusion Prostaglandin E 1 can improve muscular strength , reduce morbility and improve life quality of those patients .

结论前列腺素E1能明显改善脑梗塞患者偏瘫侧肌力，降低致残率，提高患者生活质量，值得临床应用。

Effects of Prostaglandin E 1 for Patients with Congenital Heart Disease Associated with Pulmonary Hypertension before Open Heart Surgery

前列腺素E1治疗先心病并肺动脉高压

Evaluation of Patients Treated with Lipo-prostaglandin E 1 for Chronic Severe Type B Hepatitis by MELD Prognosis Analysis

应用MELD预后分析评价前列腺素E1脂微球载体制剂治疗慢性乙型重型肝炎的疗效

Designment of E 1 and E 2 transitions above absorption edge of HgCdTe

碲镉汞吸收缘以上E1和E2峰的指认

Conclusion : The method was accurate , simple , rapid and can be used to determine the Prostaglandins E 1 for Injection .

结论：本法检测结果准确、可靠，可用于控制注射用前列腺素E1的质量。

The magnitude and spatial distribution characters of the electric field E 1 are analyzed according to experiment result employing a model of moving vessel .

根据一次船模实验，分析了运动舰船产生的感应电场的大小及空间分布特性。

Conclusion : PG E 1 through portal vein administered can provide effective protection against liver warm ischemia reperfusion injury in rats .

结论：经门静脉输注PGE1是一种新的、安全的对常温下肝缺血再灌注损伤的有效保护方法。

Firstly , combining the e 1 optimization and deadbeat control scheme we present a procedure for designing the optimal robust steady tracking controller .

首选将e1优化控制器的有限拍设计方法结合给出了最优鲁棒稳态跟踪控制器的设计方法。

Fifteen patients with severe esophageal varices were given sclerotherapy by ST E 1 cannulation for 25 times .

应用ST－E1透明套管对15例食道静脉重度曲张患者进行共25例次硬化治疗。

Study on the Effects of Modified Euro Collins Solution With Prostaglandin E 1 and Low Potassium Dextran Solution on Rabbit Lung Preservation

Euro－Collins液加前列腺素E1与低钾右旋糖酐液低温保存供体兔肺18h的实验研究

Objective : To observe the effect of prostaglandins E 1 ( PGE 1 ) on the disease of acute cerebral infarction .

目的：观察前列腺素E1（PGE1）治疗急性脑梗死疗效。

Objective To investigate the effect of prostaglandin E 1 ( PGE 1 ) on acute thromboembolic pulmonary hypertension in pig model .

目的研究前列腺素E1对栓塞性肺动脉高压的作用。

Low dose heparin and lipo prostaglandin E 1 were used in prophylactic regimen for hepatic veno-occlusive disease .

以霉酚酸酯加环孢素A和短程氨甲蝶呤预防移植物抗宿主病，低剂量肝素和前列腺素E1脂质微球预防肝静脉阻塞病。

Objective : To establish the UV Spectrophotometry method of the determination of Prostaglandins E 1 for Injection by the method of isomer alkali .

目的：采用碱异构化法对注射用前列腺素E1进行含量测定。

Objective To study the therapeutic effect of liposomal prostaglandin E 1 ( lipo PGE 1 ) on severe pulmonary contusion .

目的：观察静脉应用脂微球&前列腺素E1（lipoPGE1）治疗急性肺挫伤疗效。

At 24 h AI in experimental groups ( E 1 , E 2 , E 3 ) was significantly less than in control group ( P0.05 ) .

24h实验组AI明显低于对照组（P0.05）。